Alzheimer’s disease (AD) and other neurodegenerative diseases are some of the most difficult medical conditions in the world, characterized by progressive cognitive decline, neuronal death, memory loss, and many molecular pathologies, from tau protein hyperphosphorylation to mitochondrial dysfunction and chronic oxidative stress.
Research into alternative and adjunct therapies has brought new interest in the field of hydrogen therapy, including inhalation, water, and saline modalities, as a therapeutic antioxidant approach with promising therapeutic potential.
Hydrogen inhalation therapy is emerging as a promising, non-invasive support for Alzheimer’s disease by targeting oxidative stress and neuroinflammation.
Research in animals shows that hydrogen gas may protect brain cells, improve memory, and reduce amyloid-related damage.
Molecular hydrogen can cross the blood-brain barrier, making inhalation a highly effective delivery method for neurological support.
Early human studies suggest that hydrogen may help slow cognitive decline, though more clinical trials are needed for confirmation.
Safe, portable devices like the AirForest hydrogen inhalation machine offer accessible ways to explore this therapy at home.
Molecular hydrogen (H₂) is a colorless, physiologically inert gas under normal conditions that, when used in controlled settings as a therapeutic medical gas, may act on many neurological and systemic diseases. There are several application methods:
Hydrogen gas inhalation treatment
Drinking hydrogen water and hydrogen rich water
Hydrogen rich saline and hydrogen saturated saline
Hyperbaric hydrogen therapy
These modalities are being studied for conditions from cognitive decline and ischemic brain injury to chronic obstructive pulmonary disease, myocardial ischemia reperfusion injury, and even post-cardiac arrest syndrome.
Hydrogen’s main clinical benefit comes from its ability to reduce oxidative stress. The accumulation of reactive oxygen species and cytotoxic oxygen radicals (like hydroxyl radicals - OH and peroxynitrite ONOO–) is the basis of neuronal apoptosis and neuronal loss in acute cerebral infarction, ischemic brain injury, and AD (1, 2).
Molecular hydrogen therapy directly scavenges specific cytotoxic oxygen radicals without disrupting vital redox signaling.
Oxidative stress markers such as lipid peroxidation products (MDA) are significantly reduced after hydrogen administration (3, 4).
Hydrogen also modulates inflammatory cytokines such as tumor necrosis factor α (TNF-α) and nitric oxide (NO), both of which contribute to neuronal injury and blood-brain barrier dysfunction in AD (5).
Hydrogen’s anti-oxidative stress effects help maintain mitochondrial function, enhance neuronal survival and prevent neuronal apoptosis.
Animal models (including female transgenic AD mice) showed that hydrogen gas inhalation treatment reduces learning and memory impairment by attenuating mitochondrial injury and decreasing tau phosphorylation (6).
In traumatic brain injury, hydrogen alleviates oxidative stress damage and neuronal cell loss, which is crucial in preventive and therapeutic applications for neuroprotection.
Hydrogen’s small, non-polar nature allows it to cross the blood-brain barrier easily so that it can act quickly within brain tissue.
This is in contrast to many antioxidant supplements that have limited central nervous system delivery.
Randomized controlled clinical studies and open-label pilot trials in AD patients and those with mild cognitive impairment showed that hydrogen therapy (inhalation or drinking hydrogen water) can:
Improve cognitive function (measured by ADAS-cog and MMSE scores)
Increase brain-derived neurotrophic factor (BDNF), supporting neuronal growth and repair
Reduce oxidative stress markers and lower tau protein accumulation (7, 8)
Subgroup analysis suggests potential benefits for cognitive impairment gender differences, but more research is needed.
Patients with acute cerebral ischemia (acute cerebral infarction) or post-cardiac arrest syndrome treated with low-concentration hydrogen gas or hydrogen-rich saline showed reduced neuronal death, improved neurological outcomes, and decreased oxidative stress (9).
Randomized clinical trials are ongoing to evaluate efficacy and safety, usually comparing hydrogen to standard treatments like tissue plasminogen activator (tPA).
In conditions like chronic obstructive pulmonary disease, myocardial ischemia reperfusion injury, and other neurodegenerative diseases, hydrogen shows broad anti-inflammatory, anti-oxidative, and protective effects (10).
Hydrogen works by inhibiting lipid peroxidation, reducing nitric oxide-related toxicity and suppressing brain inflammation via cytokine modulation (TNF-α, IL-1β, etc.).
It is also thought to inhibit AD progression by protecting against mitochondrial dysfunction and oxidative, excitotoxic or inflammatory neuronal damage.
Among all hydrogen delivery methods, inhalation provides the highest systemic levels and fastest onset—making it the best method for brain effects.
Hydrogen therapy is generally very safe, with no major side effects reported in animal or human studies. Even in high doses, hydrogen gas is:
Non-toxic
Non-addictive
Well-tolerated, even in elderly individuals
The only caution: hydrogen gas becomes flammable at concentrations above 4% in air. Most medical-grade inhalation machines stay below this threshold for safety.
While large-scale human trials are ongoing, hydrogen therapy is already used in hospitals and wellness clinics in Japan and China. Some patients report better sleep, clearer thinking and improved mood.
In Singapore, more people are trying hydrogen inhalation as a complementary therapy—often through home-use machines like the AirForest hydrogen inhalation system, which delivers safe concentrations directly through a nasal cannula.
✅ Note: Always consult a doctor before starting any new therapy, especially for neurodegenerative diseases.
While preclinical studies, small clinical trials, and randomized clinical trials show benefits of hydrogen therapy in supporting cognitive function and brain injury in AD and other conditions, large-scale, multi-center studies are needed.
Ongoing research is exploring the therapeutic potential of hydrogen as both a preventive and therapeutic medical gas, focusing on:
Understanding the mechanisms of molecular hydrogen
Optimal delivery methods (inhalation, saline, water)
Other neurodegenerative diseases and ischemic brain injury models
If you want to try hydrogen inhalation for brain support, consider the AirForest Hydrogen Inhalation Machine from The H2 Therapy.
This device delivers 1.5L/min of safe hydrogen gas for personal use and has been used by individuals with various health goals—from recovery to cognitive support.
Hydrogen inhalation is not a cure for Alzheimer’s, but the early data is promising. As research continues to uncover its neuroprotective effects, families and caregivers will soon have another tool to support brain health—one that’s safe, natural and evidence-based.
If you’re supporting a loved one with Alzheimer’s or just want to protect your cognitive function as you age, hydrogen therapy is worth looking into—and trying.
Always consult your doctor before starting any hydrogen treatment, especially for serious neurological or cardiac conditions.
No, but it may slow it down and protect brain cells.
Yes. Studies have shown it’s non-toxic and safe at therapeutic levels.
Its small size allows it to cross the blood-brain barrier and reduce oxidative stress and inflammation.
Hydrogen inhalation delivers higher concentrations directly to the bloodstream and brain.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.
1. Ohsawa, I., et al. (2007). "Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals." Nature Medicine, 13, 688–694. View Source (Accessed on 9 Aug 2025)
2. Kinji Ohno, Mikako Ito, Masatoshi Ichihara, Masafumi Ito. (2012). "Molecular Hydrogen as an Emerging Therapeutic Medical Gas for Neurodegenerative and Other Diseases" Oxid Med Cell Longev. 2012 Jun 8;2012:353152. View Source (Accessed on 9 Aug 2025)
3. Md Habibur Rahman, Cheol-Su Kim, Kyu-Jae Lee. (2024). "Molecular hydrogen gas and its therapeutic potential in recent disease progression" Med Gas Res. 2024 Sep 25;15(1):120–121. View Source (Accessed on 9 Aug 2025)
4. Ling Zhao, You-bin Wang, Shi-rui Qin, Xue-mei Ma, Xue-jun Sun, Ming-lian Wang, Ru-gang Zhong. (2013). "Protective effect of hydrogen-rich saline on ischemia/reperfusion injury in rat skin flap." J Zhejiang Univ Sci B. 2013 May;14(5):382-91. View Source (Accessed on 9 Aug 2025)
5. Fengjiao Wang, Guangjie Zhang, Qingfeng Zhai. (2025). "Role and mechanism of molecular hydrogen in the treatment of Parkinson’s diseases" Front. Neurosci., 23 April 2025. Sec. Neurodegeneration. Volume 19. View Source (Accessed on 9 Aug 2025)
6. Xin Tan, Fang Shen, Wan-Li Dong, Yi Yang, Gang Chen. (2019). "The role of hydrogen in Alzheimer’s disease." Med Gas Res. 2019 Jan 9;8(4):176–180. View Source (Accessed on 9 Aug 2025)
7. Kiyomi Nishimaki, Takashi Asada, Ikuroh Ohsawa, Etsuko Nakajima, Chiaki Ikejima, Takashi Yokota, Naomi Kamimura, Shigeo Ohta. (2018). "Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment." Curr Alzheimer Res. 2018 Mar 14;15(5):482-492. View Source (Accessed on 9 Aug 2025)
8. Hirohisa Ono, Yoji Nishijima, Shigeo Ohta. (2023). "Therapeutic Inhalation of Hydrogen Gas for Alzheimer’s Disease Patients and Subsequent Long-Term Follow-Up as a Disease-Modifying Treatment: An Open Label Pilot Study". Pharmaceuticals (Basel). 2023 Mar 13;16(3):434. View Source (Accessed on 9 Aug 2025)
9. Hirohisa Ono, Yoji Nishijima, Shigeo Ohta, Masaki Sakamoto, Kazunori Kinone, Tohru Horikosi, Mituyuki Tamaki, Hirosi Takeshita, Tomoko Futatuki, Wataru Ohishi, Taichi Ishiguro, Saori Okamoto, Shou Ishii, Hiroko Takanami. (2017). "Hydrogen Gas Inhalation Treatment in Acute Cerebral Infarction: A Randomized Controlled Clinical Study on Safety and Neuroprotection." J Stroke Cerebrovasc Dis. 2017 Nov;26(11):2587-2594. View Source (Accessed on 9 Aug 2025)
10. Fatmanur Yıldız, Tyler W. LeBaron, Duried Alwazeer. (2025). "A comprehensive review of molecular hydrogen as a novel nutrition therapy in relieving oxidative stress and diseases: Mechanisms and perspectives." Biochemistry and Biophysics Reports Volume 41, March 2025, 101933. View Source (Accessed on 9 Aug 2025)
You must be logged in to post a comment.